Table 1.
Category | Response | n (%) |
---|---|---|
Age | ||
20–29 | 3 (1) | |
30–39 | 128 (22) | |
40–49 | 300 (53) | |
50 or more | 140 (25) | |
Race | ||
White | 551 (96) | |
Other | 20 (4) | |
Married | ||
Yes | 431 (75) | |
No | 125 (22) | |
Other/no response | 15 (34) | |
Retinopathy | ||
None or nonproliferative (ETDRS <12) | 340 (60) | |
Proliferative (ETDRS ≥12) | 231 (40) | |
Nephropathy | ||
None (albumin excretion rate [AER] <40 mg/24 hour) | 411 (72) | |
Microalbuminuria (40 ≤ AER < 300) | 102 (18) | |
Albuminuria (AER ≥300) | 58 (10) | |
Hypertension (sitting sBP ≥140 mm Hg and/or dBP ≥90 mm Hg or use of antihypertensive medication) | ||
No | 313 (55) | |
Yes | 258 (45) | |
Peripheral neuropathy ever during DCCT and EDIC* | ||
No | 384 (67) | |
Yes | 187 (33) | |
Coronary calcification | ||
None | 357 (63) | |
Any | 214 (37) | |
Erectile dysfunction | ||
Not sexually active | 49 (9) | |
Yes (IIEF score 0–20) | 193 (34) | |
No (IIEF score 21 or higher) | 329 (58) | |
Sexual desire score | ||
0–7 (abnormal) | 315 (55) | |
8 or higher (normal) | 256 (45) | |
Orgasmic function score | ||
0–7 (abnormal) | 114 (20) | |
8 or higher (normal) | 457 (80) |
Defined in DCCT by the presence of definite clinically evident distal symmetrical polyneuropathy and an abnormal nerve conduction study or in EDIC by MNSI >6 positive responses on the questionnaire or a score >2 on the examination.
DCCT = Diabetes Control and Complications Trial; EDIC = Epidemiology of Diabetes Intervention and Complication; ETDRS = Early Treatment Diabetic Retinopathy Study; MNSI = Michigan Neuropathy Screening Index.